Summary
The effect of 1 μM deoxycytidine (dC) on Ara-C conversion to Ara-CTP and on inhibition of DNA synthesis by Ara-C was measured in intact leukaemic myeloblasts. dC decreased Ara-CTP production in blasts with high Ara-C phosphorylation, but not those with low activity. The Ki for dC was similar to values found with partially purified deoxycytidine kinase. The change in Ara-CTP concentration was associated with a proportional reduction in inhibition of DNA synthesis. dC decreased the effects of Ara-C by inhibition of Ara-CTP production, rather than by production of dCTP and competition with Ara-CTP. Since low Ara-CTP production in patients' blasts is a predictor of poor therapeutic response to Ara-C, the use of dC with Ara-C may improve the therapeutic index in this group of patients.
Similar content being viewed by others
References
Ahern T, Taylor GA, Sanderson CJ (1976) An evaluation of an assay for DNA synthesis in lymphocytes with (3H) thymidine and harvesting onto glass fibre filter dises. J Immunol Methods 10:329–336
Bodey GP, Freireich EJ, Monto RW, Hewlett JS (1969) Cytosine arabinoside (NSC-63878) therapy for acute leukaemia in adults. Cancer Chemother Rep 53:59–66
Buchman VM, Belyanchikova NK, Mkheidze DM, Litovchenko TA, Lichinitser MR, Barkhotkina MF, Svet-Moldavsky GJ (1979) 2-deoxycytidine hydrochloride protection of mice against the lethal cytotoxicity of cytosine arabinoside. Cancer Chemother Pharmacol 3:229–234
Chabner BA, Johns DG, Coleman CN, Drake JC, Evans WH (1974) Purification and properties of cytidine deaminase from normal and leukaemic granulocytes. J Clin Invest 53:922–931
Cheng Y-C, Domin BA, Lee LS (1976) Purification and characterisation of human deoxycytidine kinase isoenzymes from blast cells of a patient with acute myelocytic leukaemia. Fed Proc 35:462
Coleman CN, Stoller RG, Drake JC, Chabner BA (1975) Deoxycytidine kinase properties of the enzyme from human leukaemic granulocytes. Blood 46:791–803
Cooper RA, Perry S, Breitman TR (1966) Pyrimidine metabolism in human leukocytes. 1. Contribution of oxogenous thymidine to DNA-thymine and its effect on thymine nucleotide synthesis in leukaemic leukocytes. Cancer Res 26:2267–2275
Durham JP, Ives DH (1969) Deoxycytidine kinase. 1. Distribution in normal and neoplastic tissues and inter-relationships of deoxycytidine and 1B-D-arabinofuranosylcytosine phosphorylation. Mol Pharmacol 5:358–375
Durham JP, Ives DH (1970a) Deoxycytidine kinase. II. Purification and properties of the calf thymus enzyme. J Biol Chem 245:2276–2284
Durham JP, Ives DH (1970b) Deoxycytidine kinase. III. Kinetics and allosteric regulation of the calf thymus enzyme. J Biol Chem 245:2285–2294
Furlong NB, Gresham C (1971) Inhibition of DNA synthesis but not poly-dAT synthesis by arabinose analogue of cytidine in vitro. Nature New Biol 233:212–213
Hande KR, Chabner BA (1978) Pyrimidine nucleoside monophosphate kinase from human leukaemic blast cells. Cancer Res 38:579–585
Harris AL, Potter C, Bunch C, Boutagy J, Harvey DJ, Grahame-Smith DG (1979) Pharmacokinetics of cytosine arabinoside in patients with acute myeloid leukaemia. Br J Clin Pharmacol 8:219–227
Harris AL, Grahame-Smith DG, Potter CG, Bunch C (to be published) Cytosine arabinoside deamination in human leukaemic myeloblasts and resistance to cytosine arabinoside therapy. Clin Sic
Henderson JF, Brox LW, Fraser JH, Lomax CA, McCoy EE, Snyder F, Sombor G (1975) Models and methods for biochemical studies of resistance in man. In: Pharmacological basis of cancer chemotherapy. Williams & Wilkins, Baltimore, pp 663–680
Kessel D (1968) Properties of deoxycytidine kinase partially purified from L1210 cells. J Biol Chem 243:4729–4744
Kessel D, Hall TC, Rosenthal D (1969) Uptake and phosphorylation of cytosine arabinoside by normal and leukaemic blood cells in vitro. Cancer Res 29:459–463
Kozai Y, Sugino Y (1971) Enzymatic phosphorylation of 1-B-D-arabinofuranosylcytosine. Cancer Res 31:1376–1382
Meyers MB, Kreis W (1976) Purification of deoxycytidine kinase from two P815 murine neoplasms and their separation from deoxyguanosine kinase. Arch Biochem Biophys 177:10–15
Mintz CG, Agent C, Furlong NB (1976) A rapid enzymatic procedure for production of 1 B-D-(3H)-arabinofuranosylcytosine 5′triphosphate. Anal Biochem 75:153–159
Momparler RL, Brent TP, Labitan A, Krygier V (1971) Studies on the phosphorylation of cytosine arabinoside in mammalian cells. Mol Pharmacol 7:413–419
Mourad N, Parks RE Jr (1966) Erythrocyte nucleoside diphosphokinase. J Biol Chem 241:271–278
Mulder JH, Harrap KR (1975) Cytosine arabinoside uptake by tumour cells in vitro. Eur J Cancer 11:373–380
Munro HN, Fleck A (1968) The determination of nucleic acids. Methods Biochem Anal 14:113–176
Plagemann PG, Marz R, Wohlhueter RM (1978) Transport and metabolism of deoxycytidine and 1-B-D-arabinofuranosylcytosine into cultured Novikoff rat hepatoma cells: relationship to phosphorylation and regulation of triphosphate synthesis. Cancer Res 38:978–989
Randerath K, Randerath E (1966) Ion-exchange thin-layer chromatography. XV. Preparation properties and applications of paper like PEI-cellulose sheets. J Chromatogr 22:110–117
Schrecker AW (1970) Metabolism of 1-B-D-arabinofuranosylcytosine in leukaemia L1210: nucleoside and nucleotide kinases in cell-free extracts. Cancer Res 30:632–641
Stoller RG, Myers CE, Chasner BA (1978) Analysis of cytidine deaminase and tetrahydrouridine interaction by use of ligand techniques. Biochem Pharmacol 27:53–59
Tattersall MNH, Ganeshaguru K, Hoffbrand AV (1974) Mechanisms of resistance of human acute leukaemia cells to cytosine arabinoside. Br. J Haematol 27:29–46
Young RSK, Fischer GA (1968) The action of arabinosylcytosine on synchronously growing populations of mammalian cells. Biochem Biophys Res Commun 32:23–29
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Harris, A.L., Grahame-Smith, D.G. Cytosine arabinoside triphosphate production in human leukaemic myeloblasts: Interactions with deoxycytidine. Cancer Chemother. Pharmacol. 5, 185–192 (1981). https://doi.org/10.1007/BF00258478
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00258478